Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Sangamo Therapeutics, Inc. SGMO

Set alert

Price alert · SGMO

All alert types
0.07 USD 0.00 0.00%

At close · Jul 1

0.15 +0.07 +98.38%

After hours · Jul 1, 4:00 PM ET

Bid
0.18 × 20,000
Ask
0.18 × 110,000
0.0637 Day range 0.13

52-week range unavailable

YTD
-82.38%
1 year
-87.29%
Open
0.13
Prev close
0.074
Mkt cap
498.67M
Vol
28.50M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.0637
High
0.13
Forward P/E
-10.86
Beta
0.00
Short ratio
1.70
Inst. own
27.02%
Dividend
0.00
Ex-div date
50-d avg
1.94
200-d avg
0.98075
1y target
6.33

3M chart

Chart tools
Interval
1m5m15m30m

Signals (18)
NameDateAgo
SMA: BearishJun 23, 20264 months ago
MACD: Sell SignalJun 23, 20264 months ago
RSI: OversoldJun 23, 20264 months ago
MACD: Buy SignalJun 22, 20264 months ago
SMA: BullishJun 15, 20264 months ago
MACD: Sell SignalJun 10, 20264 months ago
SMA: BearishJun 9, 20264 months ago
SMA: BearishJun 8, 20264 months ago
SMA: BullishJun 5, 20265 months ago
SMA: BearishJun 4, 20265 months ago
SMA: BullishJun 3, 20265 months ago
SMA: BullishMay 26, 20265 months ago
MACD: Buy SignalMay 13, 20265 months ago
RSI: OversoldApr 29, 20266 months ago
MACD: Sell SignalApr 24, 20266 months ago
RSI: OversoldApr 24, 20266 months ago
MACD: Buy SignalApr 15, 20266 months ago
RSI: OversoldMar 31, 20267 months ago

Analyst view

Consensus: buy

Buy
Price target (mean) 6.33 +8458.6% upside
Target (low)
2.00
Target (mean)
6.33
Target (high)
10.00
Ratings (0m) 8 5 buy · 3 hold · 0 sell
  • Strong buy2
  • Buy3
  • Hold3
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 8
  • 1 month ago 8
  • 2 months ago 8

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

SGMO analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter0.000.00 – 0.000.000.0%8.84M+333.0%0
Next quarter0.000.00 – 0.000.000.0%31.50M+6448.9%0
Current year0.000.00 – 0.000.000.0%59.15M-66.4%0
Next year0.000.00 – 0.000.000.0%96.49M+63.1%0

Upgrades and downgrades

The latest rating changes

SGMO analyst upgrades and downgrades
DateFirmActionFromTo
Dec 20, 2024HC Wainwright & Co.ReiteratedBuyBuy
Dec 19, 2024HC Wainwright & Co.ReiteratedBuyBuy
Dec 10, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 14, 2024BarclaysMaintainedOverweightOverweight
Nov 5, 2024HC Wainwright & Co.MaintainedBuyBuy
Oct 23, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 22, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 22, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jul 31, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jul 24, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 19, 2024HC Wainwright & Co.ReiteratedBuyBuy
Mar 14, 2024RBC CapitalReiteratedSector PerformSector Perform
Mar 13, 2024HC Wainwright & Co.MaintainedBuyBuy
Feb 12, 2024HC Wainwright & Co.ReiteratedBuyBuy
Feb 6, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jan 19, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 7, 2023Truist SecuritiesDowngradeBuyHold
Nov 6, 2023HC Wainwright & Co.MaintainedBuyBuy
Nov 6, 2023Wells FargoDowngradeOverweightEqual-Weight
Nov 3, 2023RBC CapitalDowngradeOutperformSector Perform
Aug 15, 2023Truist SecuritiesMaintainedBuyBuy
Aug 14, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 11, 2023WedbushMaintainedOutperformOutperform
Aug 10, 2023Wells FargoMaintainedOverweightOverweight
Aug 9, 2023BarclaysMaintainedOverweightOverweight
Aug 9, 2023RBC CapitalMaintainedOutperformOutperform
May 10, 2023Truist SecuritiesMaintainedBuyBuy
May 1, 2023HC Wainwright & Co.Maintained—Buy